Physician profile
Bonnie Beaver
NPI 1235153974
$1,005.68
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $691 · 2020: $267 · 2021: $47.99.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $323.33 | 2019-2020 | |
| Radius Health, INC. | $179.03 | 2019 | |
| Shire North American Group INC | $120.74 | 2019 | |
| Pfizer INC. | $113.09 | 2019-2020 | |
| Lilly USA, LLC | $89.04 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.99 | 2021 | |
| Roche Diagnostics Corporation | $40.38 | 2019 | |
| Aspira Women'S Health INC | $30.47 | 2019 | |
| Sunovion Pharmaceuticals INC. | $22.22 | 2019 | |
| Octapharma USA, INC. | $20.96 | 2019 | |
| Lupin INC. | $18.43 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bonnie Beaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.